Aerpio Pharmaceuticals, Inc.
Aerpio Pharmaceuticals, Inc. (ARPO) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 79 transactions totaling $16.1M, demonstrating a bullish sentiment with $12.4M in net insider flow. The most recent transaction on Jun 30, 2021 involved a transaction of 8,140 shares valued at $12.4K.
ARPO Insider Activity Summary
Who Is Buying ARPO Stock?
No significant insider buying has been recorded for ARPO in the recent period.
Who Is Selling ARPO Stock?
No significant insider selling has been recorded for ARPO in the recent period.
Is Aerpio Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ARPO is bullish with an Insider Alignment Score of 89/100 and a net flow of $12.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ARPO Frequently Asked Questions
Understanding ARPO Insider Activity
Insider trading at Aerpio Pharmaceuticals, Inc. (ARPO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading ARPO stock, having executed 79 transactions in the past 90 days. The most active insider is Muneer A. Satter (Executive), who has made 32 transactions totaling $8.2M.
Related Tools
Track Aerpio Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at ARPO file new Form 4 transactions